NCT02943681View on ClinicalTrials.gov

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

NACompletedINTERVENTIONAL
Enrollment

3,812

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2021

Conditions
Child MortalityChild Morbidity
Interventions
BIOLOGICAL

Measles vaccine

Trial Locations (1)

Unknown

Bandim Health Project, Apartado 861, Bissau

All Listed Sponsors
lead

Bandim Health Project

OTHER

NCT02943681 - A Second Dose of Measles Vaccine (MV) in the Second Year of Life | Biotech Hunter | Biotech Hunter